Biodexa Pharmaceuticals (BDRX) said Monday the US Food and Drug Administration granted fast-track designation for eRapa as a potential treatment for familial adenomatous polyposis.
Shares surged 44% as intraday trading volume catapulted to over 20.5 million from a daily average of about 139,000.
DatChat (DATS) disclosed Monday the upcoming launch of its Myseum platform, a digital content management and storage solution for families, groups, and individuals.
Shares jumped 10%, with intraday trading volume rising to nearly 860,000 compared with a daily average of more than 8.72 million.
Axsome Therapeutics (AXSM) shares surged 22% after the firm said Monday it agreed to a settlement with Teva Pharmaceuticals (TEVA) to resolve "all" patent litigation related to Auvelity.
More than 3.4 million shares traded intraday compared with a daily average of about 800,000.
Price: 5.83, Change: +1.76, Percent Change: +43.24
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。